Apolipoprotein A-V (APOA5) (N-Term) Peptide
APOA5
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5512631
Quick Overview for Apolipoprotein A-V (APOA5) (N-Term) Peptide (ABIN5512631)
Target
APOA5
(Apolipoprotein A-V (APOA5))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequence
- TQARKGFWDY FSQTSGDKGR VEQIHQQKMA REPATLKDSL EQDLNNMNKF
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-APOA5 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
Apolipoprotein A-V (APOA5) peptide
APOA5 Reactivity: Human Host: Synthetic BP, Imm
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- APOA5 (Apolipoprotein A-V (APOA5))
-
Background
-
The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified.
Alias Symbols: RAP3, APOAV
Protein Size: 366 -
Gene ID
- 116519
-
NCBI Accession
- NM_001166598, NP_001160070
-
UniProt
- Q6Q788
Target
-
You are here:
